GADD 45 α and γ interaction with CDK 11 p 58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration

The epithelium-specific Ets transcription factor, SPDEF, plays a critical role in metastasis of prostate and breast cancer cells. While enhanced SPDEF expression blocks migration and invasion, knockdown of SPDEF expression enhances migration, invasion, and metastasis of cancer cells. SPDEF expression and activation is tightly regulated in cancer cells; however, the precise mechanism of SPDEF regulation has not been explored in detail. In this study we provide evidence that the cell cycle kinase CDK11p58, a protein involved in G2/M transition and degradation of several transcription factors, directly interacts with and phosphorylates SPDEF on serine residues, leading to subsequent ubiquitination and degradation of SPDEF through the proteasome pathway. As a consequence of CDK11p58 mediated degradation of SPDEF, this loss of SPDEF protein results in increased prostate cancer cell migration and invasion. In contrast, knockdown of CDK11p58 protein expression by interfering RNA or SPDEF overexpression inhibit migration and invasion of cancer cells. We demonstrate that CDK11p58 mediated degradation of SPDEF is attenuated by Growth Arrest and DNA damage-inducible 45 (GADD45) α and , two proteins inducing G2/M cell cycle arrest. We show that GADD45 α and γ, directly interact with CDK11p58 and thereby inhibit CDK11p58 activity, and consequentially SPDEF phosphorylation and degradation, ultimately reducing prostate cancer cell migration and invasion. Our findings provide new mechanistic insights into the complex regulation of SPDEF activity linked to cancer metastasis and characterize a previously unidentified SPDEF/ CDK11p58/GADD45α/γ pathway that controls SPDEF protein stability and SPDEFmediated effects on cancer cell migration and invasion.

[1]  S. Koul,et al.  The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells. , 2014, The Journal of Biological Chemistry.

[2]  C. Morrison,et al.  High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy , 2014, The Prostate.

[3]  N. Gray,et al.  Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation , 2012, Clinical Cancer Research.

[4]  Joshua J. Steffan,et al.  The Transcription Factor SPDEF Suppresses Prostate Tumor Metastasis* , 2012, The Journal of Biological Chemistry.

[5]  T. Libermann,et al.  GADD45 proteins: central players in tumorigenesis. , 2012, Current molecular medicine.

[6]  David P Turner,et al.  Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression , 2011, The Prostate.

[7]  Yichao Wu,et al.  Novel agents and new therapeutics in castration-resistant prostate cancer , 2011, Current opinion in oncology.

[8]  David P Turner,et al.  Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms. , 2011, Genes & cancer.

[9]  M. Bhasin,et al.  Requirement of the Epithelium-specific Ets Transcription Factor Spdef for Mucous Gland Cell Function in the Gastric Antrum* , 2010, The Journal of Biological Chemistry.

[10]  R. Meacham,et al.  Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF , 2010, Molecular Cancer.

[11]  Zhaohui S. Qin,et al.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.

[12]  A. Malek,et al.  ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer , 2010, PloS one.

[13]  P. L. Bergsagel,et al.  Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6. , 2010, Blood.

[14]  David P Turner,et al.  PDEF is a negative regulator of colon cancer cell growth and migration , 2009, Journal of cellular biochemistry.

[15]  Jianxin Gu,et al.  CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation. , 2009, Biochemical and biophysical research communications.

[16]  R. Singal,et al.  Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target. , 2009, Cancer research.

[17]  T. Libermann,et al.  Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex. , 2009, Journal of proteome research.

[18]  V. Findlay,et al.  Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. , 2008, Molecular biology of the cell.

[19]  R. Shah,et al.  Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.

[20]  J. Geradts,et al.  Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression. , 2007, Human pathology.

[21]  Hanzhou Wang,et al.  Cyclin D3/CDK11p58 Complex Is Involved in the Repression of Androgen Receptor , 2007, Molecular and Cellular Biology.

[22]  M. Valentine,et al.  CDK11p58 is required for the maintenance of sister chromatid cohesion , 2007, Journal of Cell Science.

[23]  M. Bhasin,et al.  Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. , 2007, Cancer research.

[24]  Fengzhi Li,et al.  Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo , 2007, Breast Cancer Research and Treatment.

[25]  Hung-Hsi Chen,et al.  Identification and Characterization of the CDK12/Cyclin L1 Complex Involved in Alternative Splicing Regulation† , 2022 .

[26]  G. Giannelli,et al.  Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. , 2005, Gastroenterology.

[27]  Towia A. Libermann,et al.  GADD45 Deregulation in Cancer: Frequently Methylated Tumor Suppressors and Potential Therapeutic Targets , 2005, Clinical Cancer Research.

[28]  B. Hoffman,et al.  GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress , 2002, Journal of cellular physiology.

[29]  T. Libermann,et al.  PDEF, a Novel Prostate Epithelium-specific Ets Transcription Factor, Interacts with the Androgen Receptor and Activates Prostate-specific Antigen Gene Expression* , 2000, The Journal of Biological Chemistry.

[30]  E. Fearon,et al.  Cancer progression , 1999, Current Biology.

[31]  W. Fiers,et al.  Cleavage of PITSLRE Kinases by ICE/CASP-1 and CPP32/CASP-3 during Apoptosis Induced by Tumor Necrosis Factor* , 1997, The Journal of Biological Chemistry.

[32]  Chun-jian Qi,et al.  Ligation or cross-linking of CD40 has different effects on AGS gastric cancer cells. , 2009, Cellular immunology.